Skip to content
Wells Fargo Analyst Shares Positive Outlook on Oscar Healths Future
On May 17, 2023, Wells Fargo analyst Stephen Baxter shared his positive outlook on Oscar Health. He maintains an Overweight rating and has raised the price target from $6.75 to $8.5. Baxter believes that Oscar Health’s goal of achieving health plan profitability in 2023 and total company profitability in 2024 is achievable. He also highlights that Oscar Health offers a more affordable membership plan compared to its competitors, which is likely to attract more consumers. Despite a challenging year, the future looks bright for the health insurance company.
‘
OSCR Stock: Stable Performance, Impressive Revenue Growth, and Undervalued Stock
On May 17, 2023, OSCR stock opened at 6.88, slightly higher than its previous close of 6.85. Throughout the day, the stock traded between a range of 6.80 and 6.95. The volume of shares traded was 51,268, significantly lower than the average volume of 1,064,397 shares traded over the past three months. OSCR’s market capitalization was $1.5 billion.
OSCR is a company in the health services sector, specifically in managed health care. OSCR’s revenue growth for the past year was 115.57%, indicating significant growth in the company’s top line. However, its net profit margin was -15.30%, indicating that the company is currently operating at a loss. The P/E ratio for OSCR was not available, but its price/sales ratio was 0.13, and its price/book ratio was 1.71. These ratios suggest that OSCR’s stock is currently undervalued.
OSCR’s next reporting date is August 10, 2023, and the EPS forecast for this quarter is -$0.24. While this forecast is negative, it is important to note that OSCR is in a growth phase, and it is not uncommon for companies to operate at a loss during this time.
In conclusion, OSCR’s stock performance on May 17, 2023, was relatively stable, with a slight increase in price from the previous close. While the company is currently operating at a loss, its revenue growth has been impressive, and its stock may be undervalued. Investors should keep an eye on OSCR’s upcoming earnings report and future growth prospects.
Oscar Health Inc (OSCR) Stock Price Forecast and Analysis for 2023
On May 17, 2023, Oscar Health Inc (OSCR) started the day at a price of $6.80 per share. According to CNN Money, the 6 analysts who offer 12-month price forecasts for OSCR have a median target of $7.00, with a high estimate of $9.00 and a low estimate of $5.40. The median estimate represents a +3.02% increase from the last price of $6.80.
The current consensus among 6 polled investment analysts is to hold stock in Oscar Health Inc, which has held steady since February.
Oscar Health Inc reported a loss of $0.24 per share in the current quarter, with sales of $1.4 billion.
Investors should keep an eye on the upcoming earnings report from Oscar Health Inc on August 10, 2023, as it could provide more insight into the company’s financial performance and potentially impact the stock price.
